Biotest - Why are we developing another agent for the treatment of rheumatism, when so many other treatments are already available?

Why are we developing another agent for the treatment of rheumatism, when so many other treatments are already available?

Because millions of human beings are in urgent need of it.

Rheumatoid arthritis is a serious disease of the immune system. Existing treatments bring no permanent relief to the majority of suffering patients and some have serious side effects. In around a quarter of all patients, available treatments have little or no effect. In Europe alone, several million people are affected.

The intelligent approach